Woodline Partners »

Guardian Pharmacy Svcs shares owned by Woodline Partners

Quarter-by-quarter ownership of Guardian Pharmacy Svcs shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Guardian Pharmacy Svcs

Tip: Access up to 7 years of quarterly data

All positions including Guardian Pharmacy Svcs held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Guardian Pharmacy Svcs by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.5M 568k 16.80

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Guardian Pharmacy Svcs

ClearBridge Advisors
Woodline Partners
Franklin Resources
Alyeska Investment Group
Driehaus Capital Management
Citadel Advisors
Allspring Global Investments Holdings
Peregrine Capital Management
New York State Common Retirement Fund
Lazard Asset Management
Lighthouse Investment Partners
Monashee Investment Management
Seven Grand Managers
Sei Investments
Foundry Partners

View all funds holding Guardian Pharmacy Svcs